AA
VRTX icon

Ancora Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Ancora Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$560K Buy
1,127
+77
+7% +$34.1K 0.01% 521
2026
Q1 		$469K Buy
1,050
+151
+17% +$70.4K 0.01% 539
2025
Q4 		$408K Buy
899
+62
+7% +$26.7K 0.01% 587
2025
Q3 		$328K Buy
837
+1
+0.1% +$418 0.01% 624
2025
Q2 		$372K Sell
836
-2
-0.2% -$922 0.01% 597
2025
Q1 		$406K Buy
838
+31
+4% +$14.4K 0.01% 565
2024
Q4 		$325K Hold
807
– – 0.01% 604
2024
Q3 		$375K Buy
807
+3
+0.4% +$1.44K 0.01% 564
2024
Q2 		$377K Sell
804
-78
-9% -$33.9K 0.01% 545
2024
Q1 		$369K Buy
882
+133
+18% +$56.2K 0.01% 550
2023
Q4 		$305K Sell
749
-80
-10% -$29.6K 0.01% 592
2023
Q3 		$288K Buy
829
+56
+7% +$19.6K 0.01% 585
2023
Q2 		$272K Buy
773
+15
+2% +$5.05K 0.01% 589
2023
Q1 		$239K Buy
758
+227
+43% +$68.1K 0.01% 611
2022
Q4 		$153K Buy
531
+89
+20% +$27.1K ﹤0.01% 729
2022
Q3 		$128K Sell
442
-16
-3% -$4.6K ﹤0.01% 836
2022
Q2 		$129K Buy
458
+83
+22% +$22.2K ﹤0.01% 885
2022
Q1 		$98K Buy
375
+125
+50% +$29.7K ﹤0.01% 1046
2021
Q4 		$55K Buy
250
+66
+36% +$12.8K ﹤0.01% 1223
2021
Q3 		$33K Buy
184
+74
+67% +$14.4K ﹤0.01% 1319
2021
Q2 		$22K Hold
110
– – ﹤0.01% 1330
2021
Q1 		$24K Hold
110
– – ﹤0.01% 1261
2020
Q4 		$26K Buy
110
+74
+206% +$17K ﹤0.01% 1022
2020
Q3 		$10K Buy
36
+30
+500% +$8.28K ﹤0.01% 1148
2020
Q2 		$2K Hold
6
– – ﹤0.01% 1288
2020
Q1 		$1K Hold
6
– – ﹤0.01% 1400
2019
Q4 		$1K Buy
+6
New +$1.21K ﹤0.01% 1343

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Ancora Advisors's VRTX Position: Q2 2026 in Review

Ancora Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 7.3% in Q2 2026, buying an estimated $34.1K and bringing the position to 1,127 shares worth $560K. The position accounts for 0.01% of the portfolio, ranked #521.

Ancora Advisors first reported a position in VRTX in Q4 2019 and has held it in 27 quarters since. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Ancora Advisors held 1,127 shares of Vertex Pharmaceuticals worth $560K as of Q2 2026.
  • Ancora Advisors bought 77 Vertex Pharmaceuticals shares in Q2 2026, an estimated $34.1K.
  • Vertex Pharmaceuticals made up 0.01% of Ancora Advisors's portfolio in Q2 2026, its #521 holding.
  • Ancora Advisors first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.